NCT07629401
Pre-approval Expanded Access of Retatrutide (LY3437943)
Pre-approval Expanded Access of Retatrutide (LY3437943)
AvailableVerified
Registry record
Trial details
- Trial
- Pre-approval Expanded Access of Retatrutide (LY3437943)
- ClinicalTrials.gov ID
- NCT07629401
- Indication
- Obesity, Obesity-related Complications
- Phase
- Not reported
- Study type
- Expanded_access
- Sponsor
- Eli Lilly and Company
- Enrolment
- Not reported
- Status
- Available
- Interventions
- Drug: Retatrutide
- Comparator
- Not reported
- Eligible ages
- 18 Years – No maximum
- Locations
- Not reported
- Study start
- Not reported
- Primary completion
- Not reported
- Study completion
- Not reported
Verification
- Last verified
- 4 Sept 2026
- Source
- ClinicalTrials.gov
- Registry last updated
- 6 Aug 2026